ZOPICLONE, 98.5%
ZOPICLONE, 98.5% Brand names, ZOPICLONE, 98.5% Analogs
ZOPICLONE, 98.5% Brand Names Mixture
- No information avaliable
ZOPICLONE, 98.5% Chemical_Formula
C17H17ClN6O3
ZOPICLONE, 98.5% RX_link
No information avaliable
ZOPICLONE, 98.5% fda sheet
ZOPICLONE, 98.5% msds (material safety sheet)
ZOPICLONE, 98.5% Synthesis Reference
No information avaliable
ZOPICLONE, 98.5% Molecular Weight
388.808 g/mol
ZOPICLONE, 98.5% Melting Point
178 oC
ZOPICLONE, 98.5% H2O Solubility
No information avaliable
ZOPICLONE, 98.5% State
Solid
ZOPICLONE, 98.5% LogP
-0.88
ZOPICLONE, 98.5% Dosage Forms
Tablet
ZOPICLONE, 98.5% Indication
For the short-term treatment of insomnia.
ZOPICLONE, 98.5% Pharmacology
Zopiclone is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Zopiclone is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABABZ) receptor complex. Subunit modulation of the GABABZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Zopiclone binds selectively to the brain alpha subunit of the GABA A omega-1 receptor.
ZOPICLONE, 98.5% Absorption
No information avaliable
ZOPICLONE, 98.5% side effects and Toxicity
No information avaliable
ZOPICLONE, 98.5% Patient Information
No information avaliable
ZOPICLONE, 98.5% Organisms Affected
Humans and other mammals
